Evidence map›Paper›PMID 38317153›Full record

ArticleBMC public health2024

Bisphenol A and its alternatives bisphenol S and F exposure with serum uric acid levels, hyperuricemia, and gout prevalence among US adults: a nationally representative cross-sectional study.

Shunli Jiang, Yongxin Wang, Zengliang Wang, Yaru Xu, Xi Li, Mingjia Sun, Bo Li

Abstract read
In one paragraph

Article in BMC public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Shunli Jiang *Department of Public Health, Jining Medical University, Jining, Shandong, China. utopianjiang@163.com.
Yongxin Wang *Department of Neurosurgery Center, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China.
Zengliang WangDepartment of Neurosurgery Center, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China.
Yaru XuJining Center for Disease Control and Prevention, Shandong, China.
Xi LiDepartment of Neurosurgery, Affiliated Hospital of Jining Medical University, Jining, China.
Mingjia SunDepartment of Public Health, Jining Medical University, Jining, Shandong, China.
Bo LiDepartment of Neurosurgery, Affiliated Hospital of Jining Medical University, Jining, China. libo5479937@126.com.

Funding

2022 key research and development program of Jining Science and Technology Bureau 2022YXNS031Natural Science Foundation of Xinjiang Uygur Autonomous Region 2021D01A02PhD Research Foundation of Affiliated Hospital of Jining Medical University 2021-BS-006Research Fund for the Lin He's Academician Workstation of New Medicine and Clinical Translation in Jining Medical University JYHL2021MS20Shandong Provincial Natural Science Foundation ZR2021QH249
6 · The paper itself

Abstract

backgroundRecent studies suggested inconclusive associations between bisphenols exposure and hyperuricemia risk. Our objective was to assess the potential association of bisphenol A (BPA) and its substitutes bisphenol S and F (BPS and BPF) exposure with serum uric acid (SUA) levels, hyperuricemia, and gout prevalence among US adults within the NHANES 2013-2016 datasets.

methodsMultivariable linear and logistic regression models were used to explore the associations of urinary bisphenols concentrations with SUA levels, hyperuricemia, and gout prevalence, in total population and different sex groups. The restricted cubic spline (RCS) model was used to explore the dose-response relationship.

resultsIn total population, doubling of urinary BPS and ∑BPs concentrations showed associations with an increase of 2.64 μmol/L (95% CI: 0.54, 4.74) and 3.29 μmol/L (95% CI: 0.59, 5.99) in SUA levels, respectively. The RCS model indicated a significantly "J"-shaped dose-response relationship between BPS exposure and SUA levels. Compared to the reference group of urinary BPS, males in the highest quartile displayed a 13.06 μmol/L (95% CI: 0.75, 25.37) rise in SUA levels. For females, doubling of urinary BPS concentrations was associated with a 3.30 μmol/L (95% CI: 0.53, 6.07) increase in SUA levels, with a significant linear dose-response relationship. In total population, doubling of urinary BPA concentrations showed a 1.05-fold (95% CI: 0.97, 1.14) adjusted risk of having hyperuricemia, with an inverted "U" curve. Doubling of urinary ∑BPs concentrations was associated with a 1.05-fold (95% CI: 0.96, 1.14) adjusted risk of hyperuricemia in total population, with a significant monotonic dose-response relationship. In females, doubling of urinary BPS concentrations was associated with a 1.45-fold (95% CI: 1.01, 2.08) adjusted increased risk of having gout, with a "J" shaped relationship.

conclusionsBPA and BPS exposure to some extent were associated with elevated SUA levels and increased risk of hyperuricemia, with different dose-response relationships and sex differences.

Indexed as

GoutHyperuricemiaPhenolsSulfonesAdultBenzhydryl CompoundsBisphenol A CompoundsBisphenol F CompoundsBisphenol S CompoundsCross-Sectional StudiesFemaleHumansMaleNutrition SurveysPrevalenceUric AcidBenzhydryl Compoundsbisphenol ABisphenol A Compoundsbisphenol FBisphenol F Compoundsbisphenol SBisphenol S CompoundsPhenolsSulfonesUric AcidBisphenolGoutHyperuricemiaNHANESUric acid

Identifiers

PMID38317153
PMCPMC10840165

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.